Kymab: CASE STUDY

2025-06-24T16:44:53+01:0012 January 2024|

Kymab was a therapeutic antibody company based in Cambridge, UK, developing novel solutions in drug and vaccine development. Using its unique technology with roots in the laboratories of the Wellcome Sanger Institute, the company developed broad diversity, high-quality human antibodies. Kymab's therapeutics were designed to modulate the immune system to overcome cancer immune tolerance and to treat autoimmune diseases.